---
title: "4basebio signs strategic collaboration, marketing agreement with Genezen on synthetic DNA for viral vectors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296993748.md"
description: "4basebio has entered a non-exclusive strategic collaboration and marketing agreement with viral vector CDMO Genezen. The deal grants Genezen access to 4basebio's hpDNA technology for research and clinical programs, including cell-free enzymatic DNA designed to mitigate contamination risks. Both parties will coordinate commercial activities, such as joint sales efforts and technical presentations."
datetime: "2026-08-26T06:07:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296993748.md)
  - [en](https://longbridge.com/en/news/296993748.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296993748.md)
generator: "portal-rs"
---

# 4basebio signs strategic collaboration, marketing agreement with Genezen on synthetic DNA for viral vectors

-   4basebio signed a non-exclusive strategic collaboration and marketing agreement with viral vector CDMO Genezen. \* Deal gives Genezen access to Research Use Only, high-quality, and GMP-grade hpDNA technology for development and clinical programs. \* Parties will coordinate commercial activity, including joint sales efforts and technical presentations. \* Cell-free, enzymatic DNA aims to remove microbial contamination risk and avoid antibiotic resistance genes in viral vector starting material. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4BASEBIO plc published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608260200PR\_NEWS\_PRUKDSCX\_0003) on August 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

## Related News & Research

- [DNA X regains Nasdaq stockholders’ equity compliance after panel review](https://longbridge.com/en/news/297561626.md)
- [HK Mineral Boutique owner not part of DNA Brands probe, Singapore watchdog says](https://longbridge.com/en/news/297991916.md)
- [DNA regained Nasdaq equity compliance but faces one-year mandatory monitor](https://longbridge.com/en/news/297562517.md)
- [NSE targets listing on Sep 25, reports CNBC-TV18; IFCI, NIACL shares rise up to 11%](https://longbridge.com/en/news/297998443.md)
- [Utah judge to rule if Charlie Kirk murder suspect will stand trial](https://longbridge.com/en/news/297688741.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**